Test identifies Alzheimer’s early signs
The publication of their findings marks the second breakthrough in the battle against the disease in recent months by the team at the university’s Institute of Neuroscience and Tallaght Hospital in Dublin.
The research, unveiled by TCD’s chair of psychiatry Professor Harald Hampel, is a test based on cerebrospinal fluid to detect early Alzheimer’s disease. It measures an enzyme for which high levels indicate the significant genetic risk factor of Alzheimer’s disease, found in 90% of sufferers under the age of 80.
